Anuh Pharma balance sheet

As of Mar 2026

Total assets: ₹557cr+10.0% on Mar 2025
Shareholders' equity: ₹352cr+8.0% on Mar 2025
Total debt: ₹0.0cr−100.0% on Mar 2025
Cash and investments: ₹52.9cr−27.9% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025

Non-current assets
	48.0	49.6
	0.0	0.3
	8.6	8.6
	39.6	52.0
	0.1	0.2
	5.8	15.8
	45.5	67.9
	3.9	2.1
	0.1	2.0
	106	130
Current assets
	148	74.5
	44.9	53.9
	239	216
	8.1	19.6
	0.2	0.2
	0.8	0.5
	0.9	0.3
	294	290
	10.0	11.4
	451	376
	557	507
Equity
	50.1	25.1
	302	301
	352	326
	352	326
Liabilities
	—	0.1
	0.0	0.1
	2.1	2.0
	2.1	2.1
	0.0	10.5
	188	157
	7.7	7.3
	195	175
	0.3	0.2
	2.3	0.5
	5.0	3.2
	203	179
	205	181
	557	507
Trade payables — MSME split
	2.3	1.4
	185	155

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

ANUHPHR₹79.61

Anuh Pharma Limited

· Pharma & Health

₹ CrorePeersAHCL WANBURY ZIMLAB BAJAJHCARE THEMISMED LINCOLN VALIANTLAB SIGACHIMcap ₹798 Cr

View

In ₹ Crore except Per Share As of	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	49.6	48.0	48.0
+ Capital Work-in-Progress	0.3	0.0	0.0
+ Other Intangibles	8.6	8.6	8.6
+ Non-current Investments	52.0	39.6	39.6
+ Long-term Loans	0.2	0.1	0.1
+ Other Non-current Financial Assets	15.8	5.8	5.8
Non-current Financial Assets	67.9	45.5	45.5
+ Deferred Tax Assets	2.1	3.9	3.9
+ Other Non-current Assets	2.0	0.1	0.1
Total Non-current Assets	130.5	106.1	106.1
Current Assets
+ Inventories	74.5	147.8	147.8
+ Current Investments	53.9	44.9	44.9
+ Trade Receivables	215.9	238.6	238.6
+ Cash & Cash Equivalents	19.6	8.1	8.1
+ Other Bank Balances	0.2	0.2	0.2
+ Short-term Loans	0.5	0.8	0.8
+ Other Current Financial Assets	0.3	0.9	0.9
Current Financial Assets	290.3	293.6	293.6
+ Other Current Assets	11.4	10.0	10.0
Total Current Assets	376.2	451.3	451.3
Total Assets	506.6	557.4	557.4
Equity
+ Equity Share Capital	25.1	50.1	50.1
+ Other Equity / Reserves	301.0	302.1	302.1
Equity — Owners of Parent	326.0	352.2	352.2
Total Equity	326.0	352.2	352.2
Liabilities
+ Other Non-current Financial Liab	0.1	—	—
Non-current Financial Liabilities	0.1	0.0	0.0
+ Provisions — Non-current	2.0	2.1	2.1
Non-current Liabilities	2.1	2.1	2.1
+ Borrowings — Current	10.5	0.0	0.0
+ Trade Payables	156.8	187.7	187.7
+ Other Current Financial Liab	7.3	7.7	7.7
Current Financial Liabilities	174.6	195.4	195.4
+ Provisions — Current	0.2	0.3	0.3
+ Current Tax Liabilities	0.5	2.3	2.3
+ Other Current Liabilities	3.2	5.0	5.0
Current Liabilities	178.5	203.0	203.0
Total Liabilities	180.6	205.1	205.1
Total Equity & Liabilities	506.6	557.4	557.4
Trade Payables — MSME split
+ Dues to Micro & Small — Current	1.4	2.3	2.3
+ Dues to Other Creditors — Current	155.4	185.3	185.3

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.